196 related articles for article (PubMed ID: 21350458)
1. Genzyme deal set to alter biotech landscape.
Ledford H
Nature; 2011 Feb; 470(7335):449. PubMed ID: 21350458
[No Abstract] [Full Text] [Related]
2. Making it in the biotech business.
Gewin V
Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
[No Abstract] [Full Text] [Related]
3. Roche vows to keep Genentech culture.
Hayden EC
Nature; 2009 Mar; 458(7236):270. PubMed ID: 19295574
[No Abstract] [Full Text] [Related]
4. In search of the élite.
Gewin V
Nature; 2003 Dec; 426(6967):713-7. PubMed ID: 14668879
[No Abstract] [Full Text] [Related]
5. Fourth-quarter biotech job picture.
Francisco M
Nat Biotechnol; 2011 Feb; 29(2):169. PubMed ID: 21301443
[No Abstract] [Full Text] [Related]
6. Finnish biotechnology--built on solid foundations.
Lähteenmäki R
Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
[No Abstract] [Full Text] [Related]
7. Best of both worlds.
Smaglik P
Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
[No Abstract] [Full Text] [Related]
8. Genzyme-Sanofi buy out is second largest biotech deal ever.
Ratner M
Nat Biotechnol; 2011 Apr; 29(4):293-4. PubMed ID: 21478828
[No Abstract] [Full Text] [Related]
9. Genzyme and Isis strike megadeal.
Mack GS
Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
[No Abstract] [Full Text] [Related]
10. Biogen Idec restructures, sharpens neurology focus.
Mitchell P
Nat Biotechnol; 2011 Jan; 29(1):7-8. PubMed ID: 21221080
[No Abstract] [Full Text] [Related]
11. First-quarter biotech job picture.
Francisco M
Nat Biotechnol; 2012 May; 30(5):467. PubMed ID: 22565977
[No Abstract] [Full Text] [Related]
12. Second-quarter biotech job picture.
Francisco M
Nat Biotechnol; 2015 Aug; 33(8):883. PubMed ID: 26252149
[No Abstract] [Full Text] [Related]
13. Genentech grapples with direct offer.
Huggett B
Nat Biotechnol; 2009 Mar; 27(3):212. PubMed ID: 19270652
[No Abstract] [Full Text] [Related]
14. Researchers cut loose as Pfizer and Merck shutter European sites.
Subbaraman N
Nat Biotechnol; 2011 Apr; 29(4):299-300. PubMed ID: 21478836
[No Abstract] [Full Text] [Related]
15. Sanofi Aventis grooms its ranks for biotech partnering.
Moran N
Nat Biotechnol; 2009 Jul; 27(7):581-2. PubMed ID: 19587645
[No Abstract] [Full Text] [Related]
16. Biotech boot camp.
Ledford H
Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
[No Abstract] [Full Text] [Related]
17. Pfizer explores rare disease path.
Shaffer C
Nat Biotechnol; 2010 Sep; 28(9):881-2. PubMed ID: 20829809
[No Abstract] [Full Text] [Related]
18. Biotech as an employer.
Lawrence S
Nat Biotechnol; 2007 Jan; 25(1):12. PubMed ID: 17211380
[No Abstract] [Full Text] [Related]
19. Biotech battle royale. Two firms fight over billion-dollar drug.
Sherrid P
US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209
[No Abstract] [Full Text] [Related]
20. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
